Table 1 Clinical data
From: Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients
Mean values ± SD | p-value (statin vs. baseline) | ||||||
|---|---|---|---|---|---|---|---|
Baseline | Atorvastatin | Pravastatin | Rosuvastatin | Atorvastatin | Pravastatin | Rosuvastatin | |
Age | 43.4 ± 12.5 | ||||||
BMI | 24.9 ± 7.2 | ||||||
Framingham Risk Score | 1.7 ± 0.5 | ||||||
Total Cholesterol (mg/dL) | 210.5 ± 27.6 | 138.5 ± 28.9 | 160.6 ± 28.9 | 154.2 ± 21.0 | <0.0001 | <0.0001 | <0.0001 |
LDL Cholesterol (mg/dL) | 136.2 ± 22.9 | 68.2 ± 12.1 | 88.7 ± 24 | 83.3 ± 12.7 | <0.0001 | <0.0002 | <0.0001 |
HDL Cholesterol (mg/dL) | 53.5 ± 12.9 | 54.1 ± 18.6 | 54.5 ± 13.1 | 55.3 ± 15.3 | NS | NS | NS |
C-Reactive Protein (mg/L) | 1.1 ± 1.3 | 1.05 ± 1.1 | 0.95 ± 0.8 | 1.3 ± 1.5 | NS | NS | NS |